Natural Capsules Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Natural Capsules Ltd. on BSE

Load latest

Natural Capsules Ltd.

18 Nov 2024

196.00

-3.35%

Earnings Call

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company participated in the Investors Conference Call today i.e. Monday, 18th November, 2024 on unaudited financial results for the quarter and half year ended 30th September 2024. No unpublished price sensitive information was shared/discussed in the meeting.

pdf

Natural Capsules Ltd.

13 Nov 2024

196.00

-3.35%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30, We hereby inform that unaudited financial results for the quarter and half year ended 30.09.2024 has been published in Business line-an English daily and Sanjevani-a Kannada daily. We enclose herewith copies of newspaper ad for your reference and records.

pdf

Natural Capsules Ltd.

13 Nov 2024

196.00

-3.35%

Investor Presentation

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30, Please find enclosed herewith copy of Investor Presentation in connection with unaudited financial results for the quarter and half year ended 30.09.2024.

pdf

Natural Capsules Ltd.

13 Nov 2024

196.00

-3.35%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30, Please find enslosed herewith copy of press release in connection with unaudited financials for the quarter and half year ended 30.09.2024

pdf

Natural Capsules Ltd.

12 Nov 2024

196.00

-3.35%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold a Conference Call with Investors, on Monday, 18th November, 2024 at 04.00 PM to discuss the 2nd quarter unaudited Financial results of the Company for the quarter and half year ended on 30th September, 2024 and to discuss business outlook. No price sensitive information will be disclosed or discussed.

pdf

Natural Capsules Ltd.

12 Nov 2024

196.00

-3.35%

Company Update

NATURAL CAPSULES LTD. - 524654 - Compliances-Statement Of Deviation & Variation For The Period Ended 30.09.2024

BSE India

Please find attached the statement as per Regulation 32 for the period ended 30.09.2024.

pdf

Natural Capsules Ltd.

12 Nov 2024

196.00

-3.35%

Company Update

NATURAL CAPSULES LTD. - 524654 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

The Nomination, Remuneration and Compensation Committee on their meeting held on 12.11.2024 have approved the allotment of 30,000 equity shares upon exercise of the options. The required details as per the Regulation is attached herewith.

pdf

Natural Capsules Ltd.

12 Nov 2024

196.00

-3.35%

Result

NATURAL CAPSULES LTD. - 524654 - Results-Unaudited Standalone And Consolidated Financial Results For The Quarter And …

BSE India

This is t0 inform that Board on their meeting held on 12.11.2024, have approved the unaudited consolidated and standalone financial results for the period ended 30.09.2024.

pdf

Natural Capsules Ltd.

12 Nov 2024

196.00

-3.35%

Board Meeting

NATURAL CAPSULES LTD. - 524654 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

This is to inform that the Board of the Directors at their meeting held on Tuesday, November 12th, 2024, have: 1. Approved the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024. 2. Approved for making application for listing of securities of the company on National stock exchange (NSE). 3. The Nomination Renumeration & Compensation Committee (NRC) of the company have approved the allotment of a total of 30,000 (Thirty Thousand) Equity shares of face value Rs.10/- each fully paid up against the exercise of vested Options of Employee stock option plan 2018. The Board Meeting commenced at 03.30 PM and concluded at 05.40 PM.

pdf

Natural Capsules Ltd.

04 Nov 2024

196.00

-3.35%

Board Meeting

NATURAL CAPSULES LTD. - 524654 - Board Meeting Intimation for Intimation Of Board Meeting

BSE India

NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, we wish to inform that 163rd meeting of the Board of Directors of the Company is scheduled on Tuesday, November 12, 2024, to consider and take on record, inter-alia, the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and half year ended September 30, 2024. 2. To discuss on listing of equity shares of company in National Stock Exchange (NSE). 3. Any other matters with the permission of the Chairman.

pdf

Is Natural Capsules Ltd. worth buying?

42 Votes:

Buy 85.71%

Sell 11.9%

Hold 2.38%